Balance Sheet

Accounts Payables Accumulated Expenses Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Current Assets Current Deferred Revenue Current Leases Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Long-Term Deferred Tax Long-Term Investments Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Non-Current Deffered Revenue Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Stock Liabilities Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Treasury Shares

Cash Flow Statement

Daily Values

Growth Metrics

Akebia Therapeutics (AKBA) Current Taxes (2017 - 2018)

Akebia Therapeutics has reported Current Taxes over the past 2 years, most recently at $987000.0 for Q1 2018.

Quarterly Current Taxes changed N/A to $987000.0 in Q1 2018 from the year-ago period, while the trailing twelve-month figure was $987000.0 through Mar 2018, changed N/A year-over-year, with the annual reading at $987000.0 for FY2017, N/A changed from the prior year.
Current Taxes was $987000.0 for Q1 2018 at Akebia Therapeutics, roughly flat from $987000.0 in the prior quarter.
Over five years, Current Taxes peaked at $987000.0 in Q4 2017 and troughed at $987000.0 in Q4 2017.